These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33404120)

  • 21. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creating the cannabis user: a post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004-2005).
    Acevedo B
    Int J Drug Policy; 2007 May; 18(3):177-86. PubMed ID: 17689364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.
    Hadland SE; Knight JR; Harris SK
    J Dev Behav Pediatr; 2015; 36(2):115-23. PubMed ID: 25650954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From growers to patients: Multi-stakeholder views on the use of, and access to medicinal cannabis in Australia.
    Erku D; Greenwood LM; Graham M; Hallinan CM; Bartschi JG; Renaud E; Scuffham P
    PLoS One; 2022; 17(11):e0277355. PubMed ID: 36367871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping regulatory models for medicinal cannabis: a matrix of options.
    Belackova V; Shanahan M; Ritter A
    Aust Health Rev; 2018 Aug; 42(4):403-411. PubMed ID: 28553995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Petition against "cruel" and "ridiculous" guidance on access to medicinal cannabis attracts 400 000 signatures.
    Dyer C
    BMJ; 2018 Nov; 363():k4833. PubMed ID: 30442640
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical use of cannabis: an addiction medicine perspective.
    Cook J; Lloyd-Jones DM; Ogden E; Bonomo Y
    Intern Med J; 2015 Jun; 45(6):677-80. PubMed ID: 26059881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The status of support for cannabis regulation in Uruguay 4 years after reform: Evidence from public opinion surveys.
    Cruz JM; Boidi MF; Queirolo R
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S429-S434. PubMed ID: 29230888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legalise medicinal cannabis, MPs urge.
    Gulland A
    BMJ; 2016 Sep; 354():i4986. PubMed ID: 27644232
    [No Abstract]   [Full Text] [Related]  

  • 34. The international dimension of drug policy reform in Uruguay.
    von Hoffmann J
    Int J Drug Policy; 2016 Aug; 34():27-33. PubMed ID: 27233516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deglamorising cannabis.
    Lancet; 1995 Nov; 346(8985):1241. PubMed ID: 7475708
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging Public Health Law and Policy Issues Concerning State Medical Cannabis Programs.
    Tilburg WC; Hodge JG; Gourdet C
    J Law Med Ethics; 2019 Jun; 47(2_suppl):108-111. PubMed ID: 31298127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEDICINAL CANNABIS LAW REFORM: LESSONS FROM CANADIAN LITIGATION.
    Freckelton I
    J Law Med; 2015 Jun; 22(4):719-38. PubMed ID: 26349373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Page RL; Allen LA; Kloner RA; Carriker CR; Martel C; Morris AA; Piano MR; Rana JS; Saucedo JF;
    Circulation; 2020 Sep; 142(10):e131-e152. PubMed ID: 32752884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.